| P50 | author | Susan L McElroy | Q56816544 |
| P2860 | cites work | Risk-benefit decision making for treatment of depression during pregnancy | Q73247015 |
| | Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance | Q73441541 |
| | "A two-illness model of bipolar disorder"--RT Joffe, LT Young, and GM MacQueen: a commentary | Q73634785 |
| | Prevalence of overweight and obesity in bipolar patients | Q73805994 |
| | Antipsychotics during pregnancy | Q74054742 |
| | The impact of reproductive events on the course of bipolar disorder in women | Q74069475 |
| | Sensitivity and specificity of clinical markers for the diagnosis of bipolar II disorder | Q77159207 |
| | Practice parameter: management issues for women with epilepsy (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q77441481 |
| | The emerging epidemiology of hypomania and bipolar II disorder | Q77700788 |
| | Response to lithium maintenance treatment in bipolar disorders: comparison of women and men | Q77790335 |
| | Diazepam and breast-feeding | Q93716950 |
| | Strategies to Reduce Misdiagnosis of Bipolar Depression | Q22241851 |
| | Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies | Q24623356 |
| | The high prevalence of "soft" bipolar (II) features in atypical depression | Q28265572 |
| | Nephrogenic diabetes insipidus in transplacental lithium intoxication | Q28325679 |
| | Current concepts in the polycystic ovary syndrome | Q31842930 |
| | Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group | Q33714858 |
| | The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology | Q33723078 |
| | Historical perspectives and natural history of bipolar disorder | Q33920209 |
| | Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire | Q33923768 |
| | Obstetrical and neonatal outcome following clonazepam use during pregnancy: a case series | Q33945715 |
| | The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases | Q33963449 |
| | Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment. | Q34103535 |
| | Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders | Q34106678 |
| | Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics | Q34270748 |
| | The relationship between polycystic ovary syndrome and antiepileptic drugs: a review of the evidence | Q34317530 |
| | Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence | Q34349130 |
| | Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? | Q34503731 |
| | Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania | Q35271301 |
| | Obstetric outcome in women with polycystic ovarian syndrome. | Q54023022 |
| | Breastfeeding and the Use of Human Milk | Q54173992 |
| | Lithium and pregnancy. 3. Lithium ingestion by children breast-fed by women on lithium treatment. | Q54436762 |
| | Lithium and Pregnancy--II, Hazards to Women Given Lithium During Pregnancy and Delivery | Q55381533 |
| | Admixture Analysis of Age at Onset in Bipolar I Affective Disorder | Q57698082 |
| | Correlates of overweight and obesity in 644 patients with bipolar disorder | Q60646356 |
| | The Stanley Foundation Bipolar Treatment Outcome Network | Q61480091 |
| | Effect of menstrual cycle phase and oral contraceptive use on serum lithium levels after a loading dose of lithium in normal women | Q67299449 |
| | The course of affective disorders. II. Typology of bipolar manic-depressive illness | Q67402192 |
| | Prospective multicentre study of pregnancy outcome after lithium exposure during first trimester | Q67513864 |
| | Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament | Q67590416 |
| | Classification of postpartum psychosis: a study of 250 mother and baby admissions in The Netherlands | Q68057539 |
| | Rapid cycling affective disorder: contributing factors and treatment responses in 51 patients | Q68264296 |
| | Lithium and pregnancy. I. Report from the Register of Lithium Babies | Q68507411 |
| | Lithium carbonate in obstetrics: Guidelines for clinical use | Q69579108 |
| | Abnormalities in children exposed to benzodiazepines in utero | Q69891931 |
| | Recurrent premenstrual decline in serum lithium concentration: clinical correlates and treatment implications | Q70316373 |
| | Thyroid abnormalities associated with rapid-cycling bipolar illness | Q70429738 |
| | Valproic acid in breast milk: how much is really there? | Q70508673 |
| | Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy | Q70513355 |
| | Puerperal Psychosis. Phenomena and diagnosis | Q70818503 |
| | Postpartum prophylaxis for women with bipolar disorder | Q71553433 |
| | Lifetime rates of suicide attempts among subjects with bipolar and unipolar disorders relative to subjects with other Axis I disorders | Q71660671 |
| | Menstrual disorders in women with epilepsy receiving carbamazepine | Q71734605 |
| | Depression in women: implications for health care research | Q71967766 |
| | Polycystic ovary syndrome | Q72000241 |
| | Gender differences in bipolar disorder | Q35561522 |
| | Management of bipolar disorder during pregnancy and the postpartum period | Q35729488 |
| | The many forms of bipolar disorder: a modern look at an old illness | Q35762082 |
| | Placental transfer of chlorpromazine. Case report | Q36062823 |
| | Postpartum psychiatric syndromes. | Q38621367 |
| | Self- and other-directed aggression in child and adolescent psychiatric inpatients | Q40526107 |
| | A reevaluation of risk of in utero exposure to lithium | Q40671619 |
| | Familiality of the puerperal trigger in bipolar disorder: results of a family study | Q40704858 |
| | Teratogenic effects of antiepileptic drugs: implications for the management of epilepsy in women of childbearing age. | Q40748918 |
| | Prevalence of mental disorders and psychosocial impairments in adolescents and young adults | Q40868504 |
| | Women with bipolar illness: clinical and research issues | Q40945035 |
| | Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines | Q40979339 |
| | Rapid cycling bipolar affective disorder. I. Association with grade I hypothyroidism | Q41193783 |
| | Course of psychiatric disorders across the menstrual cycle | Q41652952 |
| | Gender and bipolar illness | Q41740628 |
| | Letter: Lithium, Ebstein's anomaly, and other congenital heart defects | Q42230678 |
| | Benzodiazepine Amplification of Valproate Teratogenic Effects in Children of Mothers with Absence Epilepsy | Q42278151 |
| | Age onset of psychotic versus non-psychotic bipolar illness in men and in women | Q43428547 |
| | Altered ovarian function and cardiovascular risk factors in valproate-treated women | Q43744359 |
| | Pattern of malformations in the children of women treated with carbamazepine during pregnancy | Q43779596 |
| | Impact of insulin resistance on pregnancy complications and outcome in women with polycystic ovary syndrome | Q43814293 |
| | Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder | Q43947453 |
| | Early physical and sexual abuse associated with an adverse course of bipolar illness | Q43962518 |
| | Lamotrigine clearance during pregnancy | Q44075693 |
| | Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 |
| | Validating antidepressant-associated hypomania (bipolar III): a systematic comparison with spontaneous hypomania (bipolar II). | Q44266751 |
| | Duration and stability of the rapid-cycling course: a long-term personal follow-up of 109 patients | Q44266754 |
| | Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women? | Q44292651 |
| | Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder | Q44427295 |
| | The influence of mania and depression on the pharmacokinetics of lithium. A longitudinal single-case study | Q44781251 |
| | Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey | Q45189352 |
| | Which could be a clinically useful definition of depressive mixed state? | Q46088060 |
| | Menstrual cycle related mood changes in women with bipolar disorder | Q46396389 |
| | Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. | Q47260401 |
| | One-month prevalence of mental disorders in the United States. Based on five Epidemiologic Catchment Area sites | Q47375366 |
| | Olanzapine-exposed pregnancies and lactation: early experience | Q47665193 |
| | Rates and predictors of developing a manic or hypomanic episode 1 to 2 years following a first hospitalization for major depression with psychotic features | Q47736888 |
| | Prophylactic lithium in puerperal psychosis. The experience of three centres | Q47875344 |
| | Multi-institutional study on the teratogenicity and fetal toxicity of antiepileptic drugs: a report of a collaborative study group in Japan | Q47880779 |
| | Impact of bipolar disorder on a U.S. community sample. | Q47951026 |
| | The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey. | Q48777454 |
| | Gender differences in patients with bipolar disorder influence outcome in the medical outcomes survey (SF-20) subscale scores. | Q50881952 |
| | Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. | Q51032804 |
| | Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. | Q51032825 |
| | Obesity and endocrine disorders in women taking valproate for epilepsy. | Q51034614 |
| | Menstrual problems in women with primary affective illness | Q51291965 |
| | Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. | Q51570720 |
| | Gender differences in major depressive disorder and bipolar disorder. | Q51891488 |
| | Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. | Q52028648 |
| | Comorbidity in mania at first hospitalization | Q52044700 |
| | Side effects in the neonate from psychotropic agents excreted through breast-feeding. | Q52705498 |
| | Healthy outcome under olanzapine treatment in a pregnant woman. | Q52972855 |
| P433 | issue | 8 Suppl 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 5-18 | |
| P577 | publication date | 2004-08-01 | |
| P1433 | published in | C N S Spectrums | Q15750260 |
| P1476 | title | Bipolar disorders: special diagnostic and treatment considerations in women | |
| P478 | volume | 9 | |